<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Gut Microbes</journal-id><journal-id journal-id-type="iso-abbrev">Gut Microbes</journal-id><journal-id journal-id-type="publisher-id">KGMI</journal-id><journal-id journal-id-type="publisher-id">kgmi20</journal-id><journal-title-group><journal-title>Gut Microbes</journal-title></journal-title-group><issn pub-type="ppub">1949-0976</issn><issn pub-type="epub">1949-0984</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4988440</article-id><article-id pub-id-type="publisher-id">1186334</article-id><article-id pub-id-type="doi">10.1080/19490976.2016.1186334</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper/Report</subject></subj-group></article-categories><title-group><article-title>The mucin-degradation strategy of <italic>Ruminococcus gnavus</italic>: The importance of intramolecular <italic>trans</italic>-sialidases</article-title><alt-title alt-title-type="running-authors">E. H. CROST ET&#x000a0;AL.</alt-title><alt-title alt-title-type="running-title">GUT MICROBES</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Crost</surname><given-names>Emmanuelle H.</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tailford</surname><given-names>Louise E.</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Monestier</surname><given-names>Marie</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Swarbreck</surname><given-names>David</given-names></name><xref ref-type="aff" rid="af0002"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Henrissat</surname><given-names>Bernard</given-names></name><xref ref-type="aff" rid="af0003"><sup>c</sup></xref><xref ref-type="aff" rid="af0004"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Crossman</surname><given-names>Lisa C.</given-names></name><xref ref-type="aff" rid="af0005"><sup>e</sup></xref><xref ref-type="aff" rid="af0006"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>Juge</surname><given-names>Nathalie</given-names></name><xref ref-type="aff" rid="af0001"><sup>a</sup></xref></contrib><aff id="af0001"><label>a</label><institution>Institute of Food Research, The Gut Health and Food Safety Institute Strategic Program, Norwich Research Park</institution>, Norwich, <country>United Kingdom</country></aff><aff id="af0002"><label>b</label><institution>The Genome Analysis Center, Norwich Research Park</institution>, Norwich, <country>United Kingdom</country></aff><aff id="af0003"><label>c</label><institution>Architecture et Fonction des Macromol&#x000e9;cules Biologiques, Universit&#x000e9; Aix-Marseille, CNRS UMR 7257</institution>, <country>France</country></aff><aff id="af0004"><label>d</label><institution>Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen</institution>, <country>Denmark</country></aff><aff id="af0005"><label>e</label><institution>School of Biological Sciences, University of East Anglia</institution>, Norwich, <country>United Kingdom</country></aff><aff id="af0006"><label>f</label><institution>SequenceAnalysis.co.uk, NRP Innovation Center</institution>, Norwich, <country>United Kingdom</country></aff></contrib-group><author-notes><corresp id="an0001"><bold>CONTACT</bold> Nathalie Juge <email xlink:href="nathalie.juge@ifr.ac.uk">nathalie.juge@ifr.ac.uk</email><institution>Gut Health and Food Institute Strategic Program, Norwich Research Park</institution>, NR4 7UA Norwich, <country>UK</country></corresp><fn><p>Supplemental data for this article can be accessed on the <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1080/19490976.2016.1186334">publisher's website.</ext-link></p></fn></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>25</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>5</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>7</volume><issue>4</issue><fpage seq="3">302</fpage><lpage>312</lpage><history><date date-type="received"><day>12</day><month>2</month><year>2016</year></date><date date-type="rev-recd"><day>19</day><month>4</month><year>2016</year></date><date date-type="accepted"><day>29</day><month>4</month><year>2016</year></date></history><permissions><!--<copyright-statement content-type="description"> Emmanuelle H. Crost, Louise E. Tailford, Marie Monestier, David Swarbreck, Bernard Henrissat, Lisa C. Crossman, and Nathalie Juge. <copyright-statement>--><copyright-statement>&#x000a9; 2016 The Author(s). Published with license by Taylor &#x00026; Francis Group, LLC</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="kgmi-07-04-1186334.pdf"/><abstract><title>ABSTRACT</title><p>We previously identified and characterized an intramolecular <italic>trans</italic>-sialidase (IT-sialidase) in the gut symbiont <italic>Ruminococcus gnavus</italic> ATCC 29149, which is associated to the ability of the strain to grow on mucins. In this work we have obtained and analyzed the draft genome sequence of another <italic>R. gnavus</italic> mucin-degrader, ATCC 35913, isolated from a healthy individual. Transcriptomics analyses of both ATCC 29149 and ATCC 35913 strains confirmed that the strategy utilized by <italic>R. gnavus</italic> for mucin-degradation is focused on the utilization of terminal mucin glycans. <italic>R. gnavus</italic> ATCC 35913 also encodes a predicted IT-sialidase and harbors a Nan cluster dedicated to sialic acid utilization. We showed that the Nan cluster was upregulated when the strains were grown in presence of mucin. In addition we demonstrated that both <italic>R. gnavus</italic> strains were able to grow on 2,7-anyhydro-Neu5Ac, the IT-sialidase transglycosylation product, as a sole carbon source. Taken together these data further support the hypothesis that IT-sialidase expressing gut microbes, provide commensal bacteria such as <italic>R. gnavus</italic> with a nutritional competitive advantage, by accessing and transforming a source of nutrient to their own benefit.</p></abstract><kwd-group kwd-group-type="author"><title>KEYWORDS</title><kwd>gut bacteria</kwd><kwd>glycoside hydrolase</kwd><kwd>intestinal mucin</kwd><kwd>intramolecular <italic>trans</italic>-sialidase</kwd><kwd>mucin glycans</kwd><kwd><italic>Ruminococcus gnavus</italic></kwd><kwd>sialic acid</kwd></kwd-group><counts><fig-count count="5"/><table-count count="1"/><ref-count count="34"/><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>The gastrointestinal (GI) tract is inhabited by a diverse microbial community (microbiota) that influences host health through a number of mechanisms, including the production of metabolites, protection against pathogens, and interactions with the host immune system and physiology. The microbiota composition varies longitudinally along the GI tract but also transversally from the mucosa to the lumen.<xref rid="cit0001" ref-type="bibr"><sup>1</sup></xref> In the large intestine, the mucus shows a bi-layer organization, with the outer layer providing a habitat to the bacteria whereas the inner layer keeps them away from the epithelium surface.<xref rid="cit0002" ref-type="bibr"><sup>2</sup></xref> Mucins facilitate microbial tropism through the presentation of glycans which may impact colonization.<xref rid="cit0003" ref-type="bibr"><sup>3</sup></xref> The terminal mucin O-glycans have been proposed to serve as metabolic substrates, providing a nutritional advantage to bacteria which have adapted to the GI mucosal environment.<xref rid="cit0004" ref-type="bibr"><sup>4,5</sup></xref> Given the diversity and complexity of intestinal mucin glycan structures, strategies for deconstructing these molecules rely on the cooperative action of a number of proteases, sulfatases, and glycosidases encoded by the genome of mucin-degrading bacteria. So far, only a limited number of bacterial species/strains from the Bacteroidetes, Firmicutes, Actinobacteria, and Verrucomicrobia phyla have been studied for their ability to consume mucins and it is becoming apparent that the strategy used by these mucin-degraders is strain and species-dependent.<xref rid="cit0005" ref-type="bibr"><sup>5</sup></xref> Based on these studies, a number of glycoside hydrolases (GH) families as classified in the CAZy database (<ext-link ext-link-type="uri" xlink:href="http://www.cazy.org">www.cazy.org</ext-link>)<xref rid="cit0006" ref-type="bibr"><sup>6</sup></xref> have been involved in mucin-degradation.<xref rid="cit0005" ref-type="bibr"><sup>5</sup></xref> These include neuraminidases/sialidases (GH33), fucosidases (GH29 and GH95), exo- and endo-&#x003b2;-N-acetylglucosaminidases (GH84 and GH85), &#x003b2;-galactosidases (GH2, GH20 and GH42), &#x003b1;-N-acetylglucosaminidases (GH89), endo-&#x003b2;1&#x02013;4-galactosidases (GH98) and &#x003b1;-N-acetylgalactosaminidases (GH101, GH129) (<ext-link ext-link-type="uri" xlink:href="http://www.cazy.org">www.cazy.org</ext-link>). Most bacteria appear to have incomplete packages of GHs for utilizing host mucins and so degradation of mucin in the human gut is likely to be carried out by a consortium of bacteria.</p><p><italic>Ruminococcus gnavus</italic> is a prominent member of the gut microbial community,<xref rid="cit0007" ref-type="bibr"><sup>7,8</sup></xref> belonging to the Firmicutes division, Clostridia class and XIVa cluster, Lachnospiraceae family.<xref rid="cit0009" ref-type="bibr"><sup>9</sup></xref> In our previous work, we showed that the ability of <italic>R. gnavus</italic> to utilize mucins was strain-dependent and associated with sialic acid metabolism although <italic>R. gnavus</italic> is not able to grow on free sialic acid (Neu5Ac).<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> We further showed that the mucin-degrader <italic>R. gnavus</italic> ATCC 29149 strain produces an intramolecular <italic>trans</italic>-sialidase (IT-sialidase) that cleaves off terminal &#x003b1;2&#x02013;3-linked sialic acid from glycoproteins, releasing 2,7-anhydro-Neu5Ac instead of sialic acid,<xref rid="cit0011" ref-type="bibr"><sup>11</sup></xref> suggesting a novel mechanism of mucosal adaptation. Here we further explored the mucin-degradation strategy of <italic>R. gnavus</italic> by expanding the work to another mucin-degrading strain, <italic>R. gnavus</italic> ATCC 35913, for which we obtained the genome sequence, and carried out comparative sequence and transcriptomics analyses and confirmed the ability of the strains to grow on 2,7-anhydro-Neu5Ac, supporting the role of IT-sialidase in the mucin-degrading strategy utilized by <italic>R. gnavus</italic>.</p></sec><sec sec-type="materials|methods" id="s0002"><title>Materials and methods</title><sec id="s0002-0001"><title>Materials</title><p>D-glucose (Glc), N-acetylneuraminic acid (Neu5Ac), 2&#x02032;-(4-Methylumbelliferyl)-&#x003b1;-D-<italic>N</italic>-acetylneuraminic acid (4MU-Neu5Ac) and type III pig gastric mucin (PGM) were purchased from Sigma-Aldrich (St Louis, MO).<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> Purified pig gastric mucin (pPGM) was obtained as previously described.<xref rid="cit0012" ref-type="bibr"><sup>12</sup></xref> 6&#x02032;-sialyllactose (6&#x02032;SL) was kindly provided by Glycom A/S (Lyngby, Denmark). 3&#x02032;-sialyllactose (3&#x02032;SL) was purchased from Carbosynth Limited (Campton, UK).</p></sec><sec id="s0002-0002"><title>Bacterial strains and growth conditions</title><p><italic>R. gnavus</italic> strains were routinely grown in an anaerobic cabinet (Don Whitley, Shipley, UK) in BHI-YH as previously described.<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> Growth on single carbon sources utilized anaerobic basal YCFA medium<xref rid="cit0013" ref-type="bibr"><sup>13</sup></xref> supplemented with 27.7&#x000a0;mM of specific mono- or oligosaccharides as indicated or 1% (wt/vol) pPGM. The growth assays were performed in 96-well plates with 200&#x000a0;&#x003bc;L of medium/well with a single point OD measurement at 595&#x000a0;nm after 44&#x000a0;hours. When the bacteria were grown with Glc or pPGM as sole carbon source with sampling for RNA extraction, the culture was performed in 14&#x000a0;mL tubes. Growth was determined spectrophotometrically by monitoring changes in optical density at 600&#x000a0;nm compared to the same medium without bacterium (&#x00394; OD600&#x000a0;nm) hourly for 9&#x000a0;hours.</p></sec><sec id="s0002-0003"><title>Genomic DNA extraction from R. gnavus ATCC 35913 and sequencing</title><p>For the isolation of <italic>R. gnavus</italic> ATCC 35913-chromosomal DNA, cells from a 50&#x000a0;mL-overnight culture were harvested by centrifugation (10 000&#x000a0;g, 5&#x000a0;min, 4&#x000b0;C). The cell pellet was washed with 5&#x000a0;mL of TES buffer (10&#x000a0;mM Tris, 1&#x000a0;mM EDTA, 0.1&#x000a0;M NaCl, pH 8), resuspended in 5&#x000a0;mL of TES buffer supplemented with lysozyme (20&#x000a0;mg.mL<sup>&#x02212;1</sup>) and incubated for 15&#x000a0;min at 37&#x000b0;C. Then, complete lysis was achieved by addition of 1&#x000a0;mL of 20% sodium dodecyl sulfate (SDS) and incubation for 10&#x000a0;min at 50&#x000b0;C. The mixture was then extracted by three consecutive treatments: first, with 5&#x000a0;mL of phenol pH 7.9 then with 5&#x000a0;mL of phenol-chloroform-isoamyl alcohol (25:24:1) and finally with 5&#x000a0;mL of chloroform-isoamyl alcohol (24:1). After precipitation with cold absolute ethanol, the genomic DNA was resuspended in 2&#x000a0;mL of TE buffer (10&#x000a0;mM Tris, 1&#x000a0;mM EDTA, pH 8). Traces of RNA were removed by a treatment with RNAse ONE (Promega, Madison, WI) used as recommended by the manufacturer. The DNA was again precipitated with 0.3&#x000a0;M sodium acetate (pH 5.2) and 70% ice-cold ethanol. Finally, it was dissolved in 1.5&#x000a0;mL of TE. Quality and quantity were assessed using NanoDrop 1000 UV-Vis Spectrophotometer and by electrophoresis on 0.7% agarose gel. The DNA was sequenced on the Roche 454 GS Flx platform using 500&#x000a0;ng of input DNA. The sequencing library was produced by the rapid library and emulsion PCR method and run on a single 454 picotiter plate at The Genome Analysis Center (TGAC). The 454 reads were assembled with Newbler (Roche) and annotated at first using Rast (NMPDR)<xref rid="cit0014" ref-type="bibr"><sup>14</sup></xref> with specific additions to the annotation from the authors, including some manual curation. The EMBL accession numbers of the annotated contigs are FCFA01000001-FCFA01000241.</p></sec><sec id="s0002-0004"><title>Comparative CAZome analysis</title><p>The translated protein sequences of <italic>R. gnavus</italic> E1, ATCC 29149 and ATCC 35913 were compared to the full length sequences derived from the Carbohydrate-Active enZymes (CAZy) database (<ext-link ext-link-type="uri" xlink:href="http://www.cazy.org">www.cazy.org</ext-link>)<xref rid="cit0015" ref-type="bibr"><sup>15</sup></xref> using BLAST.<xref rid="cit0016" ref-type="bibr"><sup>16</sup></xref> The sequences that had an e-value &#x0003e;0.1 were assigned to glycoside hydrolases (GH), glycoside transferases (GT), polysaccharide lyases (PL), carbohydrate esterases (CE), and carbohydrate binding module (CBM) families using a parallel procedure involving a BLAST search against partial sequences corresponding to individual GH, GT, PL, CE and CBM modules and a HMMer search<xref rid="cit0017" ref-type="bibr"><sup>17</sup></xref> using hidden Markov models built for each CAZy module family.<xref rid="cit0015" ref-type="bibr"><sup>15</sup></xref> The counts for each CAZy family of each strain were then compared and the putative function of the proteins of interest was evaluated by alignment with the sequences of biochemically characterized enzymes.<xref rid="cit0014" ref-type="bibr"><sup>14</sup></xref></p></sec><sec id="s0002-0005"><title>Total RNA extraction from R. gnavus strains</title><p>Total RNA was extracted from 10&#x000a0;mL of mid- to late exponential phase cultures of ATCC 29149 and ATCC 35913 in YCFA supplemented with one carbon source (Glc or pPGM). Four biological replicates were performed for each carbon source. The RNA was stabilized prior to extraction by adding 1/5 vol of phenol (pH 4.3) : ethanol (1:9) mixture to 1 vol of culture then incubating 30&#x000a0;min on ice and finally pelleting the cells for 5&#x000a0;min at 10,000&#x000a0;g at 4&#x000b0;C. Cell pellets were stored at &#x02212;80&#x000b0;C before extraction. Extraction was performed using a traditional method using phenol and chloroform. Genomic DNA contamination was removed by DNAse treatment using TURBO DNA-free kit (Life Technologies Ltd, Paisley, UK) according to supplier's recommendations. The purity, quantity and integrity of the extracted RNA were assessed before and after DNase treatment, with NanoDrop 1000 UV-Vis Spectrophotometer (Thermo Fischer Scientific, Wilmington, DE) and with Agilent RNA 600 Nano kit on Agilent 2100 Bioanalyzer (Agilent Technologies, Stockport, UK).</p></sec><sec id="s0002-0006"><title>RNA sequencing</title><p>Transcriptome libraries were constructed using the Illumina TruSeq RNA sample preparation kit with modifications. The rRNA was depleted using Ribo-Zero&#x02122; rRNA Removal Kit for Gram-Positive Bacteria (Epicentre Illumina). The rRNA removal was confirmed with a Pico chip run on Bioanalyzer 2100 (Agilent) and the quantity measured with the Qubit RNA kit and Qubit fluorometer (Invitrogen). The resulting ribosomal depleted RNA was then fragmented for 8 min at 94&#x000b0;C using the Elute, Fragment, Prime buffer from Illumina TruSeq RNA kit. These conditions give final libraries of around 400&#x000a0;bp. The samples were then processed following the standard TruSeq RNA protocol.</p><p>The 4 Illumina libraries were normalized and equimolar pooled to 15&#x000a0;nM using elution buffer (Qiagen). The library pool was then diluted to 2&#x000a0;nM with NaOH and 5&#x000a0;&#x003bc;L transferred into 995&#x000a0;&#x003bc;L HT1 (Illumina) to give a final concentration of 10 pM. A portion (120&#x000a0;&#x003bc;L) of the diluted library pool was then transferred into a 200&#x000a0;&#x003bc;L strip tube, spiked with 1% PhiX Control v3 and placed on ice before loading onto the Illumina cBot. The flow cell was clustered using TruSeq Single End Cluster Generation Kit v3, following the Illumina SE_amplification_Linearization_Blocking_PrimerHyb_v8 recipe. Following the clustering procedure, the flow cell was loaded onto the Illumina HiSeq2000 instrument following the manufacturer's instructions. The sequencing chemistry used was TruSeq SBS Kit v3-HS using HiSeq Control Software 1.4.8 and RTA 1.12.4.2. The library pool was run in a single lane for 100 cycles. Reads in bcl format were demultiplexed based on the 6&#x000a0;bp Illumina index by CASAVA 1.8, allowing for a one base-pair mismatch per library, and converted to FASTQ format by bcl2fastq.</p><p>rRNA depletion levels were assessed following read mapping. To carry this out, rRNA genes were initially manually curated on the ATCC 29149 genome. To compare the transcript expression levels across all samples, the RNA-seq reads were mapped onto the <italic>R. gnavus</italic> ATCC 29149 genome with the open source tool Bowtie v0.12.9<xref rid="cit0018" ref-type="bibr"><sup>18</sup></xref> using default parameters. Differentially expressed genes were identified using the DESeq2 R package<xref rid="cit0019" ref-type="bibr"><sup>19</sup></xref> with raw counts normalized to the effective library size. Results were also assessed using DeSeq R package,<xref rid="cit0020" ref-type="bibr"><sup>20</sup></xref> edgeR<xref rid="cit0021" ref-type="bibr"><sup>21</sup></xref> and simple RPKM normalization methods to check the DESeq2 analysis. A QC check was performed using a sample correlation matrix and plotting it as a tree. The significance of differential expression was determined by the Benjamini&#x02013;Hochberg<xref rid="cit0022" ref-type="bibr"><sup>22</sup></xref> corrected p-values of the Wald test for the negative binomial between two conditions. The threshold for significance was set to p &#x0003c; 0.05 and a Log2 (fold change) &#x0003e;1. Error bars were taken as the standard error of the Log2 fold change.</p></sec><sec id="s0002-0007"><title>Synthesis and analysis of 2,7-anhydro-Neu5Ac</title><p>The synthesis of 2,7-anhydro-Neu5Ac was carried out using a modified method.<xref rid="cit0023" ref-type="bibr"><sup>23</sup></xref> Briefly, 4-Methylumbelliferyl (MU)-Neu5Ac was incubated with recombinant IT-sialidase<xref rid="cit0011" ref-type="bibr"><sup>11</sup></xref> in ammonium formate buffer (100&#x000a0;mM) at 37&#x000b0;C, pH 6.5 overnight. The reaction was terminated by the addition of an equal volume of ethanol and the precipitate removed by centrifugation (4000&#x000a0;g for 20&#x000a0;min). The supernatant was evaporated to dryness, dissolved in chloroform/methanol and subjected to Folch partitioning. Fractions containing 2,7-anhydro-Neu5Ac were identified by thin-layer chromatography (TLC) using silica gel 60 F254 (Merck) for the stationary phase and butanol/ acetic acid/ water at a ratio 2:1:1 for the mobile phase and vizualization by incubating the TLC into a potassium permanganate solution followed by heating. The purified product was analyzed by electrospray ionization mass spectrometry (ESI-MS) and H<sup>1</sup> NMR. MS spectra were acquired on Expression CMS (Advion) with ESI ionization using direct injection operated in a negative ion mode. Advion Data Express (version 2.2.29.2) software package was used to evaluate the MS data. The <sup>1</sup>H NMR spectrum was recorded in D<sub>2</sub>O at 400&#x000a0;MHz on a Bruker Avance spectrometer (Bruker BioSpin GmbH, Rheinstetten, Germany) running Topspin 3.2 software, and was fitted with a cryoprobe. <sup>1</sup>H NMR spectrum was acquired with 16 scans, a spectral width of 8,223.6&#x000a0;Hz, an acquisition time of 3.98&#x000a0;s and a relaxation delay of 4.0&#x000a0;s. The spectrum was transformed with a 0.3-Hz line broadening, manually phased, baseline corrected and referenced by setting the water signal to 4.7 p.p.m.</p></sec></sec><sec id="s0003"><title>Results and discussion</title><sec id="s0003-0001"><title>R. gnavus ATCC 35913 grows on mucin and 3&#x02032;-sialyllactose but not on sialic acid or 6&#x02032;-sialyllactose</title><p>Previous work showed that the ability of <italic>R. gnavus</italic> to utilize mucins is strain-dependent with ATCC 29149 but not E1 being able to grow on mucins.<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> Here we tested the ability of <italic>R. gnavus</italic> ATCC 35913 to grow on mucin using purified porcine gastric mucin (pPGM) as source of carbon. <italic>R. gnavus</italic> ATCC 35913, has been isolated from fecal sample of a healthy human adult.<xref rid="cit0024" ref-type="bibr"><sup>24</sup></xref> Spectrophotometric measurements were made every hour for up to 9&#x000a0;hours (<xref ref-type="fig" rid="f0001">Fig.&#x000a0;1</xref>). The growth curves were analyzed using the in-house-developed DMFit program. For both strains the lag phase was just below 2&#x000a0;hours and the maximum &#x00394;OD at 600&#x000a0;nm was identical. As previously reported for <italic>R. gnavus</italic> ATCC 29149,<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref>
<italic>R. gnavus</italic> ATCC 35913 grew on Glc and on 3&#x02032;-sialyllactose (Neu5Ac&#x003b1;2&#x02013;3Gal&#x003b2;1&#x02013;4Glc, 3&#x02032;SL) but was unable to grow in presence of sialic acid (Neu5Ac) or 6&#x02032;-sialyllactose (Neu5Ac&#x003b1;2&#x02013;6Gal&#x003b2;1&#x02013;4Glc, 6&#x02032;SL) as sole carbon source (<xref ref-type="table" rid="t0001">Table&#x000a0;1</xref>). These data suggest that the strategy used by the mucin-degrader <italic>R. gnavus</italic> ATCC 35913 is similar to that previously reported for ATCC 291495.<xref rid="cit0005" ref-type="bibr"><sup>5,10</sup></xref>
<fig id="f0001" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Growth curves of <italic>R. gnavus</italic> ATCC 29149 and ATCC 35913 on pPGM. The growth curves represent the average growth, measured at OD600nm, of at least 3 biological replicates.</p></caption><graphic xlink:href="kgmi-07-04-1186334-g001"/></fig>
<table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Growth assay of the 3 strains of <italic>R. gnavus</italic> with several carbon sources.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/><col width="86.4pt" align="left"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th colspan="8" align="center">Carbon source<hr/></th></tr><tr><th align="left">Strain</th><th align="center">none</th><th align="center">Glc</th><th align="center">3&#x02032;SL</th><th align="center">6&#x02032;SL</th><th align="center">MU-Neu5Ac</th><th align="center">MU</th><th align="center">Neu5Ac</th><th align="center">2,7-anhydro-Neu5Ac</th></tr></thead><tbody><tr><td align="left">E1</td><td align="center">&#x02212;</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td></tr><tr><td align="left">ATCC29149</td><td align="center">&#x02212;</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">+</td></tr><tr><td align="left">ATCC35913</td><td align="center">&#x02212;</td><td align="center">+</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">+</td><td align="center">&#x02212;</td><td align="center">&#x02212;</td><td align="center">+</td></tr></tbody></table><table-wrap-foot><fn id="t1fn0001"><p><italic>Note</italic>. +: growth; &#x02212;: no growth; Glc was used as a positive control</p></fn><fn id="t1fn0002"><p>Abbreviations: Glc, glucose; 3&#x02032;SL, 3&#x02032;-sialyllactose; 6&#x02032;SL, 6&#x02032;-sialyllactose; MU-Neu5Ac, 2&#x02032;-(4-Methylumbelliferyl)-&#x003b1;-D-N-acetylneuraminic acid; MU, 4-Methylumbelliferol; Neu5Ac, N-acetylneuraminic acid; 2,7-anhydro-Neu5Ac, 2,7-anhydro-N-acetylneuraminic acid.</p></fn></table-wrap-foot></table-wrap>
</p></sec><sec id="s0003-0002"><title>In silico and transcriptomics analysis confirm IT-sialidase as a major determinant for R. gnavus mucin-degrader strains</title><p>In order to gain insights into the molecular basis of <italic>R. gnavus</italic> ATCC 35913 mucin-degradation, we sequenced and analyzed the <italic>R. gnavus</italic> ATCC 35913 genome and compared its mucin-degrading potential to that of <italic>R. gnavus</italic> ATCC 29149 and E1 strains. The draft assembly possessed 241 contigs of average length 15510&#x000a0;bp and median length of 1792&#x000a0;bp. The longest contig was 222692&#x000a0;bp, while the shortest contig was 102&#x000a0;bp. The <italic>R. gnavus</italic> ATCC 35913 genome is 3.74 Mb long with a GC content of 43%, which is similar to the GC% of E1 and ATCC 29149 (42.44% and 42.9% respectively). Genomic analysis identified 99 full length genes and 12 fragments of genes encoding CAZymes (<ext-link ext-link-type="uri" xlink:href="http://www.cazy.org">www.cazy.org</ext-link>), corresponding to approximately 2.87% of CDS dedicated to carbohydrate metabolism. <italic>R. gnavus</italic> ATCC 35913 genome contains the following number of CAZyme modules; 36 GTs, 4 CEs, 1 PL, 12 CBMs and 67 GHs. Nine of the CAZy genes encode two modules, almost always a CBM and a GH, although one of the fragments contains two GH2 domains. There are also 4 predicted proteins solely composed of a CBM (2 CBM32, 1 CBM50 and 1 CBM13) with no predicted associated catalytic module. Most of <italic>R. gnavus</italic> ATCC 35913 CAZome is represented by genes encoding GHs distributed into 26 GH families. A comparison of <italic>R. gnavus</italic> ATCC 35913 repertoire of GH families with that of <italic>R. gnavus</italic> ATCC 29149 and E1 strains is presented in <xref ref-type="fig" rid="f0002">Figure&#x000a0;2</xref>. Both mucin-degrading strains follow a similar GH representation with most GH families being common between the two strains apart from GH10 (xylanase), GH51 (endoglucanase, xylanase, L-arabinofuranosidase) and GH94 (phosphorylase) being specific of <italic>R. gnavus</italic> ATCC 35913 and GH113 (&#x003b2;-mannanase) being specific for <italic>R. gnavus</italic> ATCC 29149. Among the GH families which members have been implicated in mucin-degradation<xref rid="cit0005" ref-type="bibr"><sup>5</sup></xref> are GH2 &#x003b2;-galactosidases, GH29 and GH95 fucosidases and a GH33 sialidase. Interestingly, the genome of <italic>R. gnavus</italic> ATCC 35913 encodes a predicted GH33 sialidase sharing 100% identity with the enzyme which was characterized as an IT-sialidase in ATCC 29149, and is absent in the non-degrading strain E1. Similarly GH98 which encodes a predicted endo-&#x003b2;-galactosidase appears to be specific for the <italic>R. gnavus</italic> mucin-degrading strains. In contrast, all of the <italic>R. gnavus</italic> strains (including the E1 strain<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref>) contain multiple GH29 and GH95 &#x003b1;-fucosidases, GH2 &#x003b2;-galactosidases and a high proportion of GH13 members, which is the major GH family acting on substrates containing &#x003b1;-glucoside linkages; a detailed analysis of their substrate specificity is warranted to assess their contribution to the carbohydrate preference of each strain.
<fig id="f0002" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Comparison of the distribution of glycoside hydrolases (GHs) between <italic>R. gnavus</italic> strains. GHs are represented by light gray boxes for <italic>R. gnavus</italic> ATCC 35913, striped boxed for <italic>R. gnavus</italic> ATCC 29149 and dark gray boxes for <italic>R. gnavus</italic> E1.</p></caption><graphic xlink:href="kgmi-07-04-1186334-g002"/></fig>
</p><p>To further assess the importance of these GHs in the ability of the mucin-degrader strains to grow on mucins, we analyzed the transcriptional activity of ATCC 29149 (<xref ref-type="fig" rid="f0003">Fig.&#x000a0;3A</xref>) and ATCC 35913 (<xref ref-type="fig" rid="f0003">Fig.&#x000a0;3B</xref>) by RNAseq analysis. The level of expression was compared to a reference dataset of the strains grown in minimal medium with Glc as the sole carbon source. These data confirmed the increased transcription of the GH33 sialidase gene (<italic>nanH</italic>) when ATCC 29149 was grown with mucin, previously observed by qPCR, and are in agreement with the implication of this extracellular enzyme in enabling <italic>R. gnavus</italic> ATCC 29149 to grow on mucin.<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> Similarly the gene encoding GH33 sialidase from <italic>R. gnavus</italic> ATCC 35913 was highly upregulated in presence of mucins, the highest of all GHs (<xref ref-type="fig" rid="f0003">Fig.&#x000a0;3B</xref>). The GH98 endo-&#x003b2;1&#x02013;4-galactosidase gene expression was also induced in presence of mucin for both strains. Other mucin-specific upregulated genes included some GH29 and GH95 fucosidases (<xref ref-type="fig" rid="f0003">Fig.&#x000a0;3A and B</xref>). It is also worth noting that other GH families, not implicated in mucin-degradation, showed gene expression induction including GH13 and GH1 (mainly exo-acting enzymes cleaving a &#x003b2; linkage) family members, which raises questions on the substrate specificity of these enzymes.
<fig id="f0003" orientation="portrait" position="float"><label>Figure 3.</label><caption><p>Relative level of transcription of GH genes in <italic>R. gnavus</italic> ATCC 29149 (A) and ATCC 35913 (B). The transcriptomic analysis has been performed by RNASeq from <italic>R. gnavus</italic> grown in presence of pPGM and compared to Glc as sole carbon source. The relative level of transcription was expressed as the Log2 of the fold change in gene transcription and the figures showed averages of 4 biological replicates for the GH genes that exhibited increased transcription (Log2 fold change &#x0003e; 1). Data were analyzed by DESeq2.<xref rid="cit0019" ref-type="bibr"><sup>19</sup></xref> The significance of differential expression was determined by the Benjamini-Hochberg<xref rid="cit0021" ref-type="bibr"><sup>21</sup></xref> corrected p-values of the Wald test of the negative binomial test per each set of two conditions. The transcription level was considered significantly increased when p &#x0003c; 0.05 and a Log2 (fold change) &#x0003e;1 and significant results were labeled with *. Error bars were plotted as the standard error of the Log2 fold change.</p></caption><graphic xlink:href="kgmi-07-04-1186334-g003"/></fig>
</p></sec><sec id="s0003-0003"><title><italic>R. gnavus</italic> ATCC 35913 encodes a functional sialic acid utilization operon</title><p><italic>R. gnavus</italic> ATCC 29149 encodes an 11.7-kb Nan operon containing genes encoding putative proteins involved in the utilization of sialic acid whereas this cluster is absent in the non-mucin degrading strain <italic>R. gnavus</italic> E1.<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> Bioinformatics analysis of the <italic>R. gnavus</italic> ATCC 35913 genome suggests the presence of an 11.7- kb Nan cluster sharing 99.9% identity with the one present in ATCC 29149 and constituted of 11 open reading frames (ORFs) (<xref ref-type="fig" rid="f0004">Fig.&#x000a0;4A</xref>). The first gene of the cluster (RGNV35913_01299) is predicted to code for a GDSL-like protein belonging to the SGNH-hydrolase family, a diverse family of esterases and lipases, which comprises for example mucin-desulfating sulfatases (N-acetylglucosamine-6-sulfatases). The second gene (RGNV35913_01298) encodes a putative sugar isomerase belonging to the YhcH/YjgK/YiaL family. The following one (RGNV35913_01297) encodes a protein with homology with transcriptional regulators of the AraC family. The following 3 genes code for a predicted solute-binding protein (RGNV35913_01296) and two putative permeases (RGNV35913_01295 and RGNV35913_01294), components of a sugar ABC transporter; RGNV35913_01294 has specific homology with putative sialic acid transporters of the SAT2 family. The following gene has homology with an oxidoreductase from the Gfo/Idh/MocA family. The sialidase gene <italic>nanH</italic> (RGNV35913_01292) predicted to encode the GH33 enzyme comes next. Then <italic>nanE</italic> (RGNV35913_01291), which encodes a predicted N-acetylmannosamine-6P (ManNAc-6-P) epimerase converting ManNAc-6-P into N-acetylglucosamine-6-P (GlcNAc-6-P), followed by <italic>nanA</italic> (RGNV35913_01290) encoding a putative Neu5Ac lyase involved in the breaking down of Neu5Ac into ManNAc and pyruvate. <italic>nanK</italic> (RGNV35913_01289) is the last gene of the cluster, coding for a predicted ManNAc kinase, involved in the phosphorylation of ManNAc into ManNAc-6-P.
<fig id="f0004" orientation="portrait" position="float"><label>Figure 4.</label><caption><p>The Nan locus in <italic>R. gnavus</italic> ATCC 29149 and ATCC 35913. (A) Schematic representation of the <italic>nan</italic> genetic organization in ATCC 35913. RGNV35913_01299 encodes a putative GDSL-like protein. RGNV35913_01298encodes a putative sugar isomerase involved in sialic acid catabolism. RGNV35913_01297 encodes a protein with homology with transcriptional regulators of the AraC family. The following 3 genes code for a predicted solute-binding protein (RGNV35913_01296) and two putative permeases (RGNV35913_01295 and RGNV35913_01294), components of a sugar ABC transporter. The following gene has homology with oxidoreductases from the Gfo/Idh/MocA family. The sialidase gene <italic>nanH</italic> (RGNV35913_01292) predicted to encode the GH33 enzyme comes next. Then <italic>nanE</italic> (RGNV35913_01291), which encodes a predicted ManNAc-6-P epimerase is followed by <italic>nanA</italic> (RGNV35913_01290) encoding a putative Neu5Ac lyase. <italic>nanK</italic> (RGNV35913_01289) is the last gene of the cluster, coding for a predicted ManNAc kinase. The previously described <italic>R. gnavus</italic> ATCC 29149 nan cluster<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> shares 99.9% identity with the one present in ATCC 35913. Level of transcription of <italic>nan</italic> genes in <italic>R. gnavus</italic> ATCC 29149 (B) or ATCC 35913 (C). <italic>R. gnavus</italic> was grown in basal YCFA medium supplemented with either glucose (Glc) or mucin (pPGM) as sole carbon source. Cells were collected during the exponential phase of growth; RNA was extracted from 4 biological replicates for each carbon sources. The level of transcription of each gene was determined by RNASeq. The transcription of each gene was compared when the bacterium grew with pPGM vs. Glc using the R package DESeqx; it was considered significantly increased when the transcript was present at least twice more frequently, with a padj value (p-value adjusted for multiple testing) &#x0003c;=0.05 (* padj&#x0003c;=0.05).</p></caption><graphic xlink:href="kgmi-07-04-1186334-g004"/></fig>
</p><p>Previous data showed that the transcription of <italic>nanH</italic> was up-regulated when <italic>R. gnavus</italic> ATCC 29149 was grown in presence of mucin, as determined by microarrays and qPCR.<xref rid="cit0010" ref-type="bibr"><sup>10</sup></xref> Here we analyzed the transcriptional activity of this cluster by RNAseq analysis in both <italic>R. gnavus</italic> mucin-degrader strains grown on mucin as sole carbon source. We confirmed that all the genes involved in the release and transport of sialic acid -<italic> nanH</italic> and the 3 genes coding for an ABC transporter - as well as all the genes putatively involved in sialic acid metabolism inside the cell- were upregulated when <italic>R. gnavus</italic> ATCC 29149 and ATCC 35913 were grown with mucin (<xref ref-type="fig" rid="f0004">Fig.&#x000a0;4B and C</xref>). The average transcription of all the genes of the cluster (including <italic>nanA, nanE</italic> and <italic>nanK</italic>) was increased by at least 7&#x000a0;times when ATCC 29149 grew with pPGM as compared to Glc. Similarly, the change in transcription of the <italic>nan</italic> genes in ATCC 35913 is at least 8-fold and this increase was statistically significant for all 11 genes of the operon (<xref ref-type="fig" rid="f0004">Fig.&#x000a0;4C</xref>). These results indicate that these strains have adapted to scavenge sialic acid from host sialoglycans.</p></sec><sec id="s0003-0004"><title><italic>R. gnavus</italic> ATCC 29149 and ATCC 35913 grow on IT-sialidase transglycosylation product</title><p>In order to test the ability of <italic>R. gnavus</italic> ATCC 29149 and ATCC 35913 strains to utilize 2,7-anydro-Neu5Ac as a carbon source, we first performed the <italic>in vitro</italic> enzymatic synthesis of the transglycosylation product (not commercially available). The recombinant IT-sialidase from <italic>R. gnavus</italic> ATCC 29149 heterologously expressed in <italic>E. coli</italic><xref rid="cit0011" ref-type="bibr"><sup>11</sup></xref> was used in presence of MU-Neu5Ac to produce 2,7-anhydro-Neu5Ac in amounts enabling screening the growth of <italic>R. gnavus</italic> strains in microtiter plates. The obtained product 2,7-anhydro-Neu5Ac was &#x0223c;80% pure according to ESI-MS and H<sup>1</sup> NMR analysis (Fig.&#x000a0;S1). The by-product of the reaction, identified as MU, did not interfere with the cell growth (data not shown). We showed that both <italic>R. gnavus</italic> ATCC 35913 and ATCC 29149 could grow on MU-Neu5Ac or 2,7-anhydro-Neu5Ac as sole carbon source, while the strains were unable to grow on Neu5Ac or MU. It is worth noting that E1 was unable to grow on any of these carbon sources (<xref ref-type="table" rid="t0001">Table&#x000a0;1</xref>).</p><p>Taken together we propose a model whereby 2,7-anhydro-Neu5Ac is transported into the bacteria <italic>via</italic> the ABC transporter composed of a solute-binding protein (RUMGNA_02698 or RGNV35913_01296) and two putative permeases (RUMGNA_02697 and RUMGNA_02696, or RGNV35913_01295 and RGNV35913_01294) (<xref ref-type="fig" rid="f0005">Fig.&#x000a0;5A</xref>). It is not known whether this transporter is specific of the 2,7-anhydro-Neu5Ac or could also transport Neu5Ac. Once inside the cell, 2,7-anhydro-Neu5Ac could be hydrolyzed into Neu5Ac by the product of RUMGNA_02701 or RGNV35913_01299, which encodes a putative protein belonging to the GDSL-like family, a diverse family of esterases and lipases. This family contains SGNH-hydrolases, a sub-family of enzymes with multifunctional properties such as broad substrate specificity and regiospecificity, some of them have been shown to act as esterase on acetylated sugar e.g. NanS, an enzyme able to deacetylate the 9-O-acetyl Neu5Ac into Neu5Ac.<xref rid="cit0025" ref-type="bibr"><sup>25</sup></xref> RUMGNA_02701 or RGNV35913_01299 predicted protein possesses the four strictly conserved amino acids, Ser-Gly-Asn-His, involved in the catalytic function of these enzymes as well an Asp residue upstream of His, another feature of these enzymes.<xref rid="cit0026" ref-type="bibr"><sup>26</sup></xref> Neu5Ac would then be catabolized into GlcNAc-6-P by the successive action of NanA (Neu5Ac lyase), NanK (ManNAc kinase) and NanE (ManNAc-6-P epimerase) before entering the glycolytic pathway, in accordance with the predicted specificities of these enzymes.<xref rid="cit0027" ref-type="bibr"><sup>27</sup></xref> Alternatively it can be hypothesized that NanA shows specificity for 2,7-anhydro-Neu5Ac instead of Neu5Ac (<xref ref-type="fig" rid="f0005">Fig.&#x000a0;5B</xref>).
<fig id="f0005" orientation="portrait" position="float"><label>Figure 5.</label><caption><p>Proposed pathways for the catabolism of sialic acid in <italic>R. gnavus</italic> ATCC 29149 and ATCC 35913. <italic>Rg</italic>NanH releases 2,7-anhydro-Neu5Ac from &#x003b1;2&#x02013;3 linked sialylated substrates. (A) It can be hypothesized that 2,7-anhydro-Neu5Ac is transported inside the bacterium <italic>via</italic> a 2,7-anhydro-Neu5Ac-specific ABC transporter composed of a solute-binding protein (RUMGNA_02698 in ATCC 29149;RGNV35913_01296 in ATCC 35913) and two putative permeases (RUMGNA_02697 and RUMGNA_02696 in ATCC 29149; RGNV35913_01295 and RGNV35913_01294 in ATCC 35913) and then hydrolyzed into Neu5Ac, possibly by the action of RUMGNA_02701 or RGNV35913_01299, before being catabolized into GlcNAc-6-P following the traditional pathway by the successive action of NanA (Neu5Ac lyase), NanK (ManNAc kinase) and NanE (ManNAc-6-P epimerase). (B) Alternatively, both 2,7-anhydro-Neu5Ac and Neu5Ac could enter the cells <italic>via</italic> the ABC transporter but NanA would either be inactive or specific for 2,7-anhydro-Neu5Ac, explaining the absence of growth of the bacteria on sialic acid.</p></caption><graphic xlink:href="kgmi-07-04-1186334-g005"/></fig>
</p><p>Gaining mechanistic insights into the strategies used by members of the gut microbiota to utilize mucin glycans is important to understand how the mucus-associated ecosystem is maintained. Due to their proximity to the host immune system, mucus-associated microorganisms may have a disproportionate impact on health.<xref rid="cit0028" ref-type="bibr"><sup>28</sup></xref> Several lines of evidence indicate that mucin-degrading bacteria such as <italic>R. gnavus</italic> may play an important role in dysbiosis by increasing total mucosa-associated bacteria in inflammatory bowel diseases.<xref rid="cit0029" ref-type="bibr"><sup>29</sup></xref> Furthermore <italic>R. gnavus</italic> is involved iso-bile acid (BA) biosynthesis,<xref rid="cit0030" ref-type="bibr"><sup>30,31</sup></xref> leading to the production of secondary BAs which play a role in modulating gut community composition.<xref rid="cit0032" ref-type="bibr"><sup>32</sup></xref> Identification of keystone and foundation taxa in the mucus-associated GI microbiota is important for novel diagnostic strategies and therapeutic modulation.<xref rid="cit0033" ref-type="bibr"><sup>33</sup></xref> Keystone species of the GI microbiota have been identified for bacteria that are instrumental to the degradation of dietary resistant starch.<xref rid="cit0034" ref-type="bibr"><sup>34</sup></xref> With regards to host mucin degradation, we believe that the presence of IT-sialidases will provide gut microbes such as <italic>R. gnavus</italic> with a competitive nutritional advantage, allowing the bacteria to thrive within mucosal environments by scavenging sialic acid from host mucus in a form, 2,7-anhydro-Neu5Ac, that can be used to their own benefit. Furthermore, once the terminal sugars and blood group antigens are removed and used to support growth of <italic>R. gnavus</italic>, the mucin core glycans are exposed to enzymatic degradation by other members of the gut microbiota, thus favoring metabolic cross-feeding within this mucosal niche. This dual strategy may fit the representation of <italic>R. gnavus</italic> as a keystone member of the mucus-associated gut microbiota.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SM1102"><caption><title>KGMI_A_1186334_Figure_S1.png</title></caption><media xlink:href="kgmi-07-04-1186334-s001.png" mimetype="application" mime-subtype="png" orientation="portrait" id="d37e201" position="anchor"/></supplementary-material></sec></body><back><sec sec-type="abbreviations"><title>Abbreviations</title><p>
<def-list><def-item><term>CAZyme</term><def><p>carbohydrate-active enzyme</p></def></def-item><def-item><term>CBM</term><def><p>carbohydrate binding module</p></def></def-item><def-item><term>CDS</term><def><p>coding DNA sequence</p></def></def-item><def-item><term>GH</term><def><p>glycoside hydrolase</p></def></def-item><def-item><term>GI</term><def><p>gastrointestinal</p></def></def-item><def-item><term>Glc</term><def><p>glucose</p></def></def-item><def-item><term>IT-sialidase</term><def><p>intramolecular <italic>trans</italic>-sialidase</p></def></def-item><def-item><term>MU</term><def><p>4-methylumbelliferyl</p></def></def-item><def-item><term>Neu5Ac</term><def><p>N-acetylneuraminic acid</p></def></def-item><def-item><term>ORF</term><def><p>open reading frame</p></def></def-item><def-item><term>Ppgm</term><def><p>purified pig gastric mucin</p></def></def-item><def-item><term>SL</term><def><p>sialyllactose</p></def></def-item></def-list></p></sec><sec><title>Disclosure of potential conflicts of interest</title><p>No potential conflicts of interest were disclosed.</p></sec><sec><title>Acknowledgments</title><p>The authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council (BBSRC). Sequencing was conducted at The Genome Analysis Center (TGAC). We would like to acknowledge Simon Anders and Michael Love for their help with the analysis of RNASeq dataThe genome sequence of <italic>R. gnavus</italic> ATCC35913 has been deposited in the European Nucleotide Archive (ENA-EMBL) with the study accession number, PRJEB12317; and annotated contigs are available with accession numbers FCFA01000001-FCFA01000241.</p></sec><sec><title>Funding</title><p>This research was partly funded by The Genome Analysis Center (TGAC) Capacity and Capability Challenge Program, the BBSRC Institute Strategic Program for The Gut Health and Food Safety (BB/J004529/1) and by the BB/L008602/1 BBSRC responsive mode grant.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donaldson</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>. <article-title>Gut biogeography of the bacterial microbiota</article-title>. <source>Nat Rev Microbiol.</source>
<year>2016</year>; <volume>14</volume>:<fpage>20</fpage>-<lpage>32</lpage>; PMID:26499895; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nrmicro3552</pub-id><?supplied-pmid 26499895?><pub-id pub-id-type="pmid">26499895</pub-id></mixed-citation></ref><ref id="cit0002"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansson</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Ambort</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pelaseyed</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sch&#x000fc;tte</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gustafsson</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Ermund</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Subramani</surname><given-names>DB</given-names></name>, <name name-style="western"><surname>Holm&#x000e9;n-Larsson</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Thomsson</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Bergstr&#x000f6;m</surname><given-names>JH</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Composition and functional role of the mucus layers in the intestine</article-title>. <source>Cell Mol Life Sci</source>
<year>2011</year>; <volume>68</volume>:<fpage>3635</fpage>-<lpage>41</lpage>; PMID:21947475; http://dx.doi.org/<pub-id pub-id-type="doi">10.1007/s00018-011-0822-3</pub-id><?supplied-pmid 21947475?><pub-id pub-id-type="pmid">21947475</pub-id></mixed-citation></ref><ref id="cit0003"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juge</surname><given-names>N</given-names></name></person-group>. <article-title>Microbial adhesins to gastrointestinal mucus</article-title>. <source>Trends Microbiol</source>
<year>2012</year>; <volume>20</volume>:<fpage>30</fpage>-<lpage>39</lpage>; PMID:22088901; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.tim.2011.10.001</pub-id><?supplied-pmid 22088901?><pub-id pub-id-type="pmid">22088901</pub-id></mixed-citation></ref><ref id="cit0004"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marcobal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Southwick</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Earle</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Sonnenburg</surname><given-names>JL</given-names></name></person-group>
<article-title>A refined palate: Bacterial consumption of host glycans in the gut</article-title>. <source>Glycobiol</source>
<year>2013</year>; <volume>23</volume>:<fpage>1038</fpage>-<lpage>46</lpage>; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/glycob/cwt040</pub-id></mixed-citation></ref><ref id="cit0005"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tailford</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Crost</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Kavanaugh</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Juge</surname><given-names>N</given-names></name></person-group>. <article-title>Mucin glycan foraging in the human gut microbiome</article-title>. <source>Front Genet</source>
<year>2015</year>; <volume>6</volume>:<fpage>81</fpage>; PMID:25852737; http://dx.doi.org/<pub-id pub-id-type="doi">10.3389/fgene.2015.00081</pub-id><?supplied-pmid 25852737?><pub-id pub-id-type="pmid">25852737</pub-id></mixed-citation></ref><ref id="cit0006"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lombard</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Golaconda Ramulu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Drula</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Coutinho</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Henrissat</surname><given-names>B</given-names></name></person-group>. <article-title>The carbohydrate-active enzymes database (CAZy) in 2013</article-title>. <source>Nucleic Acids Res</source>
<year>2014</year>; <volume>42</volume>:<fpage>D490</fpage>-<lpage>5</lpage>; PMID:24270786; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/nar/gkt1178</pub-id><?supplied-pmid 24270786?><pub-id pub-id-type="pmid">24270786</pub-id></mixed-citation></ref><ref id="cit0007"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Raes</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Arumugam</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Burgdorf</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Manichanh</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Pons</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Levenez</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name>, et&#x000a0;al.</person-group>
<article-title>A human gut microbial gene catalogue established by metagenomic sequencing</article-title>. <source>Nature</source>
<year>2010</year>; <volume>464</volume>:<fpage>59</fpage>-<lpage>65</lpage>; PMID:20203603; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nature08821</pub-id><?supplied-pmid 20203603?><pub-id pub-id-type="pmid">20203603</pub-id></mixed-citation></ref><ref id="cit0008"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kraal</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Abubucker</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kota</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mitreva</surname><given-names>M</given-names></name></person-group>. <article-title>The prevalence of species and strains in the human microbiome: a resource for experimental efforts</article-title>. <source>PLoS one</source>
<year>2014</year>; <volume>9</volume>:<fpage>e97279</fpage>; PMID:24827833; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0097279</pub-id><?supplied-pmid 24827833?><pub-id pub-id-type="pmid">24827833</pub-id></mixed-citation></ref><ref id="cit0009"><label>[9]</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ludwig</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Schleifer</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Whitman</surname><given-names>WB</given-names></name></person-group>
<chapter-title>Revised road map to the phylum Firmicutes</chapter-title>&#x0201d; In: <source>Bergey's Manual of Systematic Bacteriology</source>, <edition>2nd</edition> ed., <comment>vol. 3 (The Firmicutes)</comment>
<person-group person-group-type="editor"><name name-style="western"><surname>De Vos</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Garrity</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Krieg</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Ludwig</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Rainey</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Schleifer</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Whitman</surname><given-names>WB</given-names></name></person-group>, eds., <year>2009</year>; <publisher-loc>New York</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name> pp:<fpage>1</fpage>-<lpage>13</lpage></mixed-citation></ref><ref id="cit0010"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crost</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Tailford</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Le Gall</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fons</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Henrissat</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Juge</surname><given-names>N</given-names></name></person-group>. <article-title>Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent</article-title>. <source>PLoS One</source>
<year>2013</year>; <volume>8</volume>:<fpage>e76341</fpage>; PMID:24204617; http://dx.doi.org/<pub-id pub-id-type="doi">10.1371/journal.pone.0076341</pub-id><?supplied-pmid 24204617?><pub-id pub-id-type="pmid">24204617</pub-id></mixed-citation></ref><ref id="cit0011"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tailford</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Owen</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Walshaw</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Crost</surname><given-names>EH</given-names></name>, <name name-style="western"><surname>Hardy-Goddard</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Le Gall</surname><given-names>G</given-names></name>, <name name-style="western"><surname>de Vos</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Juge</surname><given-names>N</given-names></name></person-group>. <article-title>Discovery of intramolecular trans-sialidases in human gut microbiota suggests novel mechanisms of mucosal adaptation</article-title>. <source>Nat Commun</source>
<year>2015</year>; <volume>6</volume>:<fpage>7624</fpage>; PMID:26154892; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ncomms8624</pub-id><?supplied-pmid 26154892?><pub-id pub-id-type="pmid">26154892</pub-id></mixed-citation></ref><ref id="cit0012"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunning</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Kirby</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Fuell</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pin</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tailford</surname><given-names>LE</given-names></name>, <name name-style="western"><surname>Juge</surname><given-names>N</given-names></name></person-group>. <article-title>Mining the &#x0201c;glycocode&#x0201d;-exploring the spatial distribution of glycans in gastrointestinal mucin using force spectroscopy</article-title>. <source>FASEB J</source>
<year>2013</year>; <volume>27</volume>:<fpage>2342</fpage>-<lpage>54</lpage>; PMID:23493619; http://dx.doi.org/<pub-id pub-id-type="doi">10.1096/fj.12-221416</pub-id><?supplied-pmid 23493619?><pub-id pub-id-type="pmid">23493619</pub-id></mixed-citation></ref><ref id="cit0013"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duncan</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Hold</surname><given-names>GL</given-names></name>, <name name-style="western"><surname>Harmsen</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>HJ</given-names></name></person-group>. <article-title>Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov</article-title>. <source>Int J Syst Evol Microbiol</source>
<year>2002</year>; <volume>52</volume>:<fpage>2141</fpage>-<lpage>46</lpage>; PMID:12508881<?supplied-pmid 12508881?><pub-id pub-id-type="pmid">12508881</pub-id></mixed-citation></ref><ref id="cit0014"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aziz</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Bartels</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Best</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>DeJongh</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Disz</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Edwards</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Formsma</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gerdes</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Glass</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Kubal</surname><given-names>M</given-names></name>, et&#x000a0;al.</person-group>
<article-title>The RAST Server: rapid annotations using subsystems technology</article-title>. <source>BMC Genomics</source>
<year>2008</year>; <volume>9</volume>:<fpage>75</fpage>; PMID:18261238; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/1471-2164-9-75</pub-id><?supplied-pmid 18261238?><pub-id pub-id-type="pmid">18261238</pub-id></mixed-citation></ref><ref id="cit0015"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cantarel</surname><given-names>BL</given-names></name>, <name name-style="western"><surname>Coutinho</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Rancurel</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bernard</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lombard</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Henrissat</surname><given-names>B</given-names></name></person-group>. <article-title>The carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics</article-title>. <source>Nucleic Acids Res</source>
<year>2009</year>; <volume>37</volume>:<fpage>D233</fpage>-<lpage>38</lpage>; PMID:18838391; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/nar/gkn663</pub-id><?supplied-pmid 18838391?><pub-id pub-id-type="pmid">18838391</pub-id></mixed-citation></ref><ref id="cit0016"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altschul</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Gish</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Myers</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Lipman</surname><given-names>DJ</given-names></name></person-group>. <article-title>Basic local alignment search tool</article-title>. <source>J Mol Biol</source>
<year>1990</year>; <volume>215</volume>:<fpage>403</fpage>-<lpage>10</lpage>; PMID:2231712; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><?supplied-pmid 2231712?><pub-id pub-id-type="pmid">2231712</pub-id></mixed-citation></ref><ref id="cit0017"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eddy</surname><given-names>SR</given-names></name></person-group>. <article-title>Profile hidden Markov models</article-title>. <source>Bioinformatics</source>
<year>1998</year>; <volume>14</volume>:<fpage>755</fpage>-<lpage>63</lpage>; PMID:9918945; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/bioinformatics/14.9.755</pub-id><?supplied-pmid 9918945?><pub-id pub-id-type="pmid">9918945</pub-id></mixed-citation></ref><ref id="cit0018"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Langmead</surname><given-names>B</given-names></name></person-group>
<article-title>Aligning short sequencing reads with Bowtie</article-title>. <source>Curr Protoc Bioinformatics Chapter</source>
<year>2010</year>; <volume>11</volume>:<comment>Unit 11.17</comment>; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/0471250953.bi1107s32</pub-id>.</mixed-citation></ref><ref id="cit0019"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Love</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Anders</surname><given-names>S</given-names></name></person-group>. <article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>. <source>Genome Biol</source>
<year>2014</year>; <volume>15</volume>:<fpage>550</fpage>; PMID:25516281; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><?supplied-pmid 25516281?><pub-id pub-id-type="pmid">25516281</pub-id></mixed-citation></ref><ref id="cit0020"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anders</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Huber</surname><given-names>W</given-names></name></person-group>. <article-title>Differential expression analysis for sequence count data</article-title>. <source>Genome Biol.</source>
<year>2010</year>; <volume>11</volume>: <fpage>R106</fpage>; PMID:20979621; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/gb-2010-11-10-r106</pub-id><?supplied-pmid 20979621?><pub-id pub-id-type="pmid">20979621</pub-id></mixed-citation></ref><ref id="cit0021"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Robinson</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>McCarthy</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Smyth</surname><given-names>GK</given-names></name></person-group>. <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>. <source>Bioinformatics</source>
<year>2010</year>; <volume>26</volume>:<fpage>139</fpage>-<lpage>40</lpage>; PMID:19910308; http://dx.doi.org/<pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id><?supplied-pmid 19910308?><pub-id pub-id-type="pmid">19910308</pub-id></mixed-citation></ref><ref id="cit0022"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Benjamini</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hochberg</surname><given-names>Y</given-names></name></person-group>
<article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J Royal Stat Soc Series B (Methodological)</source>
<year>1995</year>; <volume>57</volume>:<fpage>289</fpage>-<lpage>300</lpage></mixed-citation></ref><ref id="cit0023"><label>[23]</label><mixed-citation publication-type="patent"><person-group person-group-type="author"><name name-style="western"><surname>Teh</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>LS</given-names></name></person-group>
<article-title>Isolation, purification and utilization of sialidase-L in the synthesis of 2,7-anhydro-N-acetylneuraminic acid and for the selective cleavage of sialyl&#x003b1;2-3 D-galactose linkage</article-title>. <patent country="US">Patent US 5312747 A</patent>
<comment>Filing date 8 Feb 1993. Publication date 17 May</comment>
<year>1994</year></mixed-citation></ref><ref id="cit0024"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoskins</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Agustines</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McKee</surname><given-names>WB</given-names></name>, <name name-style="western"><surname>Boulding</surname><given-names>ET</given-names></name>, <name name-style="western"><surname>Kriaris</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Niedermeyer</surname><given-names>G</given-names></name></person-group>. <article-title>Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins</article-title>. <source>J Clin Invest</source>
<year>1985</year>; <volume>75</volume>:<fpage>944</fpage>-<lpage>53</lpage>; PMID:3920248; http://dx.doi.org/<pub-id pub-id-type="doi">10.1172/JCI111795</pub-id><?supplied-pmid 3920248?><pub-id pub-id-type="pmid">3920248</pub-id></mixed-citation></ref><ref id="cit0025"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rangarajan</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Ruane</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Proteau</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Schrag</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Valladares</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Gilbert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yakunin</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Cygler</surname><given-names>M</given-names></name></person-group>. <article-title>Structural and enzymatic characterization of NanS (YjhS), a 9-O-Acetyl N-acetylneuraminic acid esterase from Escherichia coli O157:H7</article-title>. <source>Protein Sci</source>
<year>2011</year>; <volume>20</volume>:<fpage>1208</fpage>-<lpage>19</lpage>; PMID:21557376; http://dx.doi.org/<pub-id pub-id-type="doi">10.1002/pro.649</pub-id><?supplied-pmid 21557376?><pub-id pub-id-type="pmid">21557376</pub-id></mixed-citation></ref><ref id="cit0026"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akoh</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Liaw</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>JF</given-names></name></person-group>. <article-title>GDSL family of serine esterases/lipases</article-title>. <source>Prog Lipid Res</source>
<year>2004</year>; <volume>43</volume>:<fpage>534</fpage>-<lpage>52</lpage>; PMID:15522763; http://dx.doi.org/<pub-id pub-id-type="doi">10.1016/j.plipres.2004.09.002</pub-id><?supplied-pmid 15522763?><pub-id pub-id-type="pmid">15522763</pub-id></mixed-citation></ref><ref id="cit0027"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghosh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Roseman</surname><given-names>S</given-names></name></person-group>. <article-title>The Sialic Acids. V. N-Acyl-D-Glucosamine 2-Epimerase</article-title>. <source>J Biol Chem</source>
<year>1965</year>; <volume>240</volume>:<fpage>1531</fpage>-<lpage>36</lpage>; PMID:14285488<?supplied-pmid 14285488?><pub-id pub-id-type="pmid">14285488</pub-id></mixed-citation></ref><ref id="cit0028"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koropatkin</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Cameron</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Martens</surname><given-names>EC</given-names></name></person-group>. <article-title>How glycan metabolism shapes the human gut microbiota</article-title>. <source>Nat Rev Microbiol</source>
<year>2012</year>; <volume>10</volume>:<fpage>323</fpage>-<lpage>35</lpage>; PMID:22491358<?supplied-pmid 22491358?><pub-id pub-id-type="pmid">22491358</pub-id></mixed-citation></ref><ref id="cit0029"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Png</surname><given-names>CW</given-names></name>, <name name-style="western"><surname>Lind&#x000e9;n</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Gilshenan</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Zoetendal</surname><given-names>EG</given-names></name>, <name name-style="western"><surname>McSweeney</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Sly</surname><given-names>LI</given-names></name>, <name name-style="western"><surname>McGuckin</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Florin</surname><given-names>TH</given-names></name></person-group>. <article-title>Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria</article-title>. <source>Am J Gastroenterol</source>
<year>2010</year>; <volume>105</volume>:<fpage>2420</fpage>-<lpage>8</lpage>; PMID:20648002; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ajg.2010.281</pub-id><?supplied-pmid 20648002?><pub-id pub-id-type="pmid">20648002</pub-id></mixed-citation></ref><ref id="cit0030"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Arai</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fukiya</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wada</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yokota</surname><given-names>A</given-names></name></person-group>. <article-title>Contribution of the 7&#x003b2;-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon</article-title>. <source>J Lipid Res</source>
<year>2013</year>; <volume>54</volume>:<fpage>3062</fpage>-<lpage>9</lpage>; PMID:23729502; http://dx.doi.org/<pub-id pub-id-type="doi">10.1194/jlr.M039834</pub-id><?supplied-pmid 23729502?><pub-id pub-id-type="pmid">23729502</pub-id></mixed-citation></ref><ref id="cit0031"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Devlin</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Fischbach</surname><given-names>MA</given-names></name></person-group>. <article-title>A biosynthetic pathway for a prominent class of microbiota-derived bile acids</article-title>. <source>Nat Chem Biol.</source>
<year>2015</year>; <volume>11</volume>:<fpage>685</fpage>-<lpage>90</lpage>; PMID:26192599; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/nchembio.1864</pub-id><?supplied-pmid 26192599?><pub-id pub-id-type="pmid">26192599</pub-id></mixed-citation></ref><ref id="cit0032"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duboc</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rajca</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Rainteau</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Benarous</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Maubert</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Quervain</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Barbu</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Humbert</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Despras</surname><given-names>G</given-names></name>, et&#x000a0;al.</person-group>
<article-title>Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases</article-title>. <source>Gut</source>
<year>2013</year>; <volume>62</volume>:<fpage>531</fpage>-<lpage>9</lpage>; PMID:22993202; http://dx.doi.org/<pub-id pub-id-type="doi">10.1136/gutjnl-2012-302578</pub-id><?supplied-pmid 22993202?><pub-id pub-id-type="pmid">22993202</pub-id></mixed-citation></ref><ref id="cit0033"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trosvik</surname><given-names>P</given-names></name>, <name name-style="western"><surname>de Muinck</surname><given-names>EJ</given-names></name></person-group>. <article-title>Ecology of bacteria in the human gastrointestinal tract&#x02013;identification of keystone and foundation taxa</article-title>. <source>Microbiome</source>
<year>2015</year>; <volume>3</volume>:<fpage>44</fpage>; PMID:26455879; http://dx.doi.org/<pub-id pub-id-type="doi">10.1186/s40168-015-0107-4</pub-id><?supplied-pmid 26455879?><pub-id pub-id-type="pmid">26455879</pub-id></mixed-citation></ref><ref id="cit0034"><label>[34]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ze</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Duncan</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Louis</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Flint</surname><given-names>HJ</given-names></name></person-group>. <article-title>Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon</article-title>. <source>ISME J</source>
<year>2012</year>; <volume>6</volume>:<fpage>1535</fpage>-<lpage>43</lpage>; PMID:22343308; http://dx.doi.org/<pub-id pub-id-type="doi">10.1038/ismej.2012.4</pub-id><?supplied-pmid 22343308?><pub-id pub-id-type="pmid">22343308</pub-id></mixed-citation></ref></ref-list></back></article>